Search by Drug Name or NDC
NDC 51662-1205-03 AMIODARONE HYDROCHLORIDE 50 mg/mL Details
AMIODARONE HYDROCHLORIDE 50 mg/mL
AMIODARONE HYDROCHLORIDE is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by HF Acquisition Co LLC, DBA HealthFirst. The primary component is AMIODARONE HYDROCHLORIDE.
Product Information
| NDC | 51662-1205 |
|---|---|
| Product ID | 51662-1205_0ef250d9-ba34-8a3e-e063-6394a90acd14 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | AMIODARONE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | AMIODARONE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/mL |
| Substance Name | AMIODARONE HYDROCHLORIDE |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Pharmaceutical Class | Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA077234 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 51662-1205-03 (51662120503)
| NDC Package Code | 51662-1205-3 |
|---|---|
| Billing NDC | 51662120503 |
| Package | 25 POUCH in 1 CASE (51662-1205-3) / 1 mL in 1 POUCH (51662-1205-2) |
| Marketing Start Date | 2020-06-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |